Purpose: It is important to reduce stress and improve quality of life for shift nurses, who experience high levels of occupational stress. Identifying evidence-based interventions to enhance their well-being is crucial for both individual and healthcare system outcomes. This study aimed to evaluate the effects of music therapy and aromatherapy on stress, quality of life, and happiness among shift nurses. Methods: In this randomized controlled trial, participants were randomly assigned using computer-generated random numbers. A total of 78 shift nurses who met the inclusion criteria were enrolled. The experimental treatment involved providing music therapy for one week to the music group and aromatherapy for one week to the aroma group, whereas the control group followed their usual daily routines for one week. Results: No significant differences were observed among the three groups concerning general characteristics and baseline dependent variables, thereby confirming the homogeneity of the groups. Nevertheless, post-intervention analyses demonstrated significant improvements in perceived stress (F = 5.55, p = .006), stress index (F = 3.38, p = .039), quality of life (F = 11.79, p < .001), and happiness (F = 9.29, p < .001) in the experimental groups. Conclusion Both music therapy and aromatherapy were found to be effective in mitigating stress and improving quality of life and happiness among shift nurses. Therefore, these interventions can be regarded as valuable strategies for improving overall well-being within this population.

Purpose: It is important to reduce stress and improve quality of life for shift nurses, who experience high levels of occupational stress. Identifying evidence-based interventions to enhance their well-being is crucial for both individual and healthcare system outcomes. This study aimed to evaluate the effects of music therapy and aromatherapy on stress, quality of life, and happiness among shift nurses. Methods: In this randomized controlled trial, participants were randomly assigned using computer-generated random numbers. A total of 78 shift nurses who met the inclusion criteria were enrolled. The experimental treatment involved providing music therapy for one week to the music group and aromatherapy for one week to the aroma group, whereas the control group followed their usual daily routines for one week. Results: No significant differences were observed among the three groups concerning general characteristics and baseline dependent variables, thereby confirming the homogeneity of the groups. Nevertheless, post-intervention analyses demonstrated significant improvements in perceived stress (F = 5.55, p = .006), stress index (F = 3.38, p = .039), quality of life (F = 11.79, p < .001), and happiness (F = 9.29, p < .001) in the experimental groups. Conclusion Both music therapy and aromatherapy were found to be effective in mitigating stress and improving quality of life and happiness among shift nurses. Therefore, these interventions can be regarded as valuable strategies for improving overall well-being within this population.

Purpose: It is important to reduce stress and improve quality of life for shift nurses, who experience high levels of occupational stress. Identifying evidence-based interventions to enhance their well-being is crucial for both individual and healthcare system outcomes. This study aimed to evaluate the effects of music therapy and aromatherapy on stress, quality of life, and happiness among shift nurses. Methods: In this randomized controlled trial, participants were randomly assigned using computer-generated random numbers. A total of 78 shift nurses who met the inclusion criteria were enrolled. The experimental treatment involved providing music therapy for one week to the music group and aromatherapy for one week to the aroma group, whereas the control group followed their usual daily routines for one week. Results: No significant differences were observed among the three groups concerning general characteristics and baseline dependent variables, thereby confirming the homogeneity of the groups. Nevertheless, post-intervention analyses demonstrated significant improvements in perceived stress (F = 5.55, p = .006), stress index (F = 3.38, p = .039), quality of life (F = 11.79, p < .001), and happiness (F = 9.29, p < .001) in the experimental groups. Conclusion Both music therapy and aromatherapy were found to be effective in mitigating stress and improving quality of life and happiness among shift nurses. Therefore, these interventions can be regarded as valuable strategies for improving overall well-being within this population.

Purpose: It is important to reduce stress and improve quality of life for shift nurses, who experience high levels of occupational stress. Identifying evidence-based interventions to enhance their well-being is crucial for both individual and healthcare system outcomes. This study aimed to evaluate the effects of music therapy and aromatherapy on stress, quality of life, and happiness among shift nurses. Methods: In this randomized controlled trial, participants were randomly assigned using computer-generated random numbers. A total of 78 shift nurses who met the inclusion criteria were enrolled. The experimental treatment involved providing music therapy for one week to the music group and aromatherapy for one week to the aroma group, whereas the control group followed their usual daily routines for one week. Results: No significant differences were observed among the three groups concerning general characteristics and baseline dependent variables, thereby confirming the homogeneity of the groups. Nevertheless, post-intervention analyses demonstrated significant improvements in perceived stress (F = 5.55, p = .006), stress index (F = 3.38, p = .039), quality of life (F = 11.79, p < .001), and happiness (F = 9.29, p < .001) in the experimental groups. Conclusion Both music therapy and aromatherapy were found to be effective in mitigating stress and improving quality of life and happiness among shift nurses. Therefore, these interventions can be regarded as valuable strategies for improving overall well-being within this population.

Background and Objectives: This study aimed to evaluate the factors that influence deep sleep restoration in patients with obstructive sleep apnea (OSA) following positive airway pressure (PAP) therapy. Methods: In total, 363 patients diagnosed with OSA who received PAP therapy over at least 3 months were enrolled in the study. Polysomnographic parameters, anatomical characteristics, and subjective sleep-related parameters were evaluated according to the presence of daytime sleepiness and morning headache before and after 3 months of PAP treatment. Results: Age was significantly different according to whether excessive daytime sleepiness (EDS) was alleviated (average: 49.35 years) or persisted (average: 52.82 years) (p=0.001). Age was also significantly associated with morning headache (p=0.037). Body mass index (BMI) was higher in the alleviated EDS group (28.70 kg/m2) than in the persistent EDS group (27.13 kg/m2; p=0.002). The apnea-hypopnea index (AHI) was correlated with the EDS outcome (p=0.011). The group with alleviated EDS had a longer mandibular plane to hyoid distance (MPH) than the group with persistent EDS (17.95 mm vs. 15.38 mm; p<0.001). However, BMI, AHI, and MPH showed no significant associations with morning headache. Epworth Sleepiness Scale scores were higher in the alleviated EDS and alleviated morning headache groups (EDS: p<0.001, morning headache: p=0.001). Self-Efficacy Measure for Sleep Apnea (SEMSA) values differed significantly between the EDS groups (p<0.001), but not between the morning headache groups (p=0.122). After 3 months of PAP therapy, the MPH was negatively correlated with EDS in univariate (odds ratio [OR]=0.921, p<0.001) and multivariate analyses (OR=0.937, p=0.028). The SEMSA score was also negatively correlated with EDS in univariate (OR=0.961, p<0.001) and multivariate (OR=0.973, p=0.019) analyses. Conclusion Age, polysomnographic metrics, and anatomical considerations were important for sleep quality-associated daytime symptoms. In addition, anatomical characteristics and the patient’s self-efficacy were significantly associated with the effect of PAP treatment on sleep quality.

Fixed drug eruption (FDE) is a well-defined hyperpigmented patch that recurs in a fixed location each time a particular drug is taken. Common causative agents of FDE are nonsteroidal anti-inflammatory drugs, non-narcotic analgesics, sedatives, anticonvulsants, sulfonamides, and tetracycline. We report a 33-year-old male who presented with a recurrent, localized, brownish-to-erythematous macule and papules on the peri-philtrum area two hours after taking valacyclovir. Three episodes of valacyclovir ingestion for treatment of Herpes simplex virus infection provoked a similar skin rash at the same site. Histopathology results showed vacuolar degeneration in the basal layer of the epidermis, pigmentary incontinence, and perivascular inflammatory cell infiltration in the papillary dermis. Although patch test and skin prick test showed negative responses to acyclovir and valacyclovir, an intradermal test showed a positive reaction only to valacyclovir. The oral provocation test to acyclovir and valacyclovir showed a positive reaction only to valacyclovir. Through drug history, histopathological examination, patch test, intradermal test, and oral provocation test, we established a final diagnosis of FDE due to valacyclovir without cross-reactivity to acyclovir. To find alternative therapeutic drugs, we suggest diagnostic tests with not only the suspected drugs, but also other drugs in the same class.

Background: Due to the COVID-19 pandemic, from 2020, many pharmaceutical companies have developed vaccines. To determine the efficacy of AstraZeneca's and Pfizer's vaccines, which were the first and second vaccines to be approved in Korea, respectively, we developed a method to measure their antibody-generating efficacies using immunology analyzers and a rapid antibody test available in Korea. Methods: The antibody-stimulating efficacies of the Pfizer and AstraZeneca vaccines were evaluated using Centaur® XPT SARS-CoV-2 (Siemens Healthineers, Germany), Elecsys® AntiSARS-CoV-2 S (Roche Diagnostics, Germany), and STANDARD F SARS-CoV-2 nAb FIA (SD Biosensor, Korea). Healthcare workers were enrolled in two groups: the Pfizer (121) and AstraZeneca (117) groups. Antibody levels were measured pre-vaccination, three weeks after vaccination, and 16 weeks after vaccination. Results: The Pfizer group comprised 41 males and 80 females, while the AstraZeneca group comprised 38 males and 79 females. Antibody results were analyzed after excluding four individuals who had recovered from COVID-19. Between weeks 3 and 16, there was no significant difference (P= 0.5, 1.0) between the results of the Roche and Siemens antibody tests in the Pfizer vaccine group. However, the SD biosensor results comparing with the Roche and Siemens antibody tests at three weeks after the initial vaccination showed a significant difference (P < 0.0001). Analysis of the Roche antibody test results before, at three weeks, and at 16 weeks after the administration of the Pfizer and AstraZeneca vaccines revealed a statistically significant difference between before and at three weeks after the first injection (P < 0.0001). Conclusion After two doses of the Pfizer and AstraZeneca vaccines, antibody formation was above the 90 th percentile of the measurement range in all subjects.

Background: It is necessary to develop a roadmap for antimicrobial usage monitoring in order to perform monitoring of antimicrobial use at the national level properly. Therefore, this study aimed to develop a roadmap for establishing surveillance and monitoring of antimicrobial use in medical institutions at the national level. Materials and Methods: A modified Delphi study was conducted, including 3 rounds of an online survey and a virtual meeting with 16 expert panels. The survey items were developed based on a literature review of the surveillance systems for antimicrobial use in 12 countries and interviews with experts. The questionnaire was designed to include both the surveillance and benchmarking systems. Results: Regarding the scope of target institutions to be included in the surveillance system, medical institutions for sentinel surveillance had the highest proportion of agreement among the panels (75.0%, 9/12). For the benchmarking system, “tertiary- and secondarycare hospitals” were accepted as the scope of target institutions at the current moment.Furthermore, the National Health Insurance claims and prescription data of individual hospitals were considered appropriate data sources for the surveillance system. As for the measures to promote the participation of hospitals in the benchmarking system, “compensation through the establishment of antimicrobial management fees” and “set the participation in the program as a quality evaluation or accreditation index for hospital evaluation” were accepted. Conclusion This study provides a roadmap for establishing an antimicrobial use monitoring and benchmarking system for medical institutions at a national level in Korea.